Control of Aldosterone in Normal and Hypertensive Pregnancy: Effects of Metoclopramide

References

• Brown MA, Broughton Pipkin F, Symonds EM. The effects of intravenous angiotensin II upon sodium and urate excretion in human pregnancy. J Hypertension 1988; 6: 457
   PubMed Web of Science ®Google Scholar
• Brown MA. Sodium balance in pregnancy. Fetal Medicine 1989; 1: 198
   Google Scholar
• Weinberger MH, Kramer NJ, Petersen LP, . Sequential changes in the rennin-angiotensin-aldosterone systems and plasma progesterone concentration in normal and abnormal human pregnancy. Hypertension in Pregnancy, MD Lindheimer, AI Katz, FP Zuspan, et al. J. Wiley & Sons, New York 1976; 263
   Google Scholar
• Brown MA. Sodium excretion in pregnancy. University of NSW, SydneyAustralia 1988; 209, (MD thesis)
   Google Scholar
• Fakunding JL, Chow R, Catt KJ. The role of calcium in the stimulation of aldosterone production by adrenocorticotropin, angiotensin II and potassium in isolated glomerulosa cells. Endocrinology 1979; 105: 327
   PubMed Web of Science ®Google Scholar
• Seeby EW, Conlin PR, Brent GA, Dluhy R. Adrenocorticotropin stimulation of aldosterone: prolonged continuous versus pulsatile infusion. J Clin Endocrinol Metab. 1989; 69: 1028
   PubMed Web of Science ®Google Scholar
• Laragh JH, Atlas SA. Atrial natriuretic hormone: a regulator of blood pressure and volume homeostasis. Kidney Int. 1988; 34: 589
   Web of Science ®Google Scholar
• Carey RM, Thorner MO, Ortt EM. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man: dopaminergic control of aldosterone. J Clin Invest. 1979; 63: 727
   PubMed Web of Science ®Google Scholar
• Noth RH, McCallum RW, Contino C., Havelick J. Tonic dopaminergic suppression of plasma aldosterone. J Clin Endocrinol Metab. 1980; 51: 64
   PubMed Web of Science ®Google Scholar
• Ehrlich EN, Lindheimer MD. Effect of administered mineralocorticoids or ACTH in pregnant women: attenuation of kaliuretic influence of mineralocorticoids during pregnancy. J Clin Invest. 1972; 51: 1301
   PubMed Web of Science ®Google Scholar
• Fievet P, Fournier A, de Bold A, El Esper N, Gregoire I, Westeel PF, et al. Atrial natriuretic factor in pregnancy-induced hypertension and preeclampsia: increased plasma concentrations possibly explaining these hypovolemic states with paradoxical hyporeninism. Am J Hypertens. 1988; 1: 16
   PubMed Web of Science ®Google Scholar
• Lowe SA, Zammit VC, Mitar DM, Macdonald GJ, Brown MA. Atrial natriuretic peptide and plasma volume in pregnancy-induced hypertension. Am J Hypertens. 1991; 4: 897
   PubMed Web of Science ®Google Scholar
• Stratta P, Canavese C., Gurioli L, Porcu M, Todros T, Mattone GC, et al. Ratio between aldosterone and atrial natriuretic peptide in pregnancy. Kidney Int. 1989; 36: 908
   PubMed Web of Science ®Google Scholar
• Albibi R, McCallum RW. Metoclopramide: pharmacology and clinical application. Ann Int Med. 1983; 98: 86
   PubMed Web of Science ®Google Scholar
• Rowe J, Gallery EDM, Gyory AZ. Cryoactivation of renin in plasma from pregnant and non-pregnant subjects, and its control. Clin Chem. 1979; 25: 1972
   PubMed Web of Science ®Google Scholar
• Brown MA, Zammit VC, Adsett D. Stimulation of active renin release in normal and hypertensive pregnancy. Clin Science 1990; 79: 505
   PubMed Web of Science ®Google Scholar
• Missale C., Lombardi C., Sigala S, Spano P. Dopaminergic regulation of aldosterone secretion. Am J Hypertens. 1990; 3: S93
   Web of Science ®Google Scholar
• Taylor AA, Fennel WH, Feldman MB, Brandon TA, Ginos JZ, Mitchell JR. Activation of peripheral dopamine presynaptic receptors lowers blood pressure and heart rate in dogs. Hypertension 1983; 5: 226
   PubMed Web of Science ®Google Scholar
• Missale C., Memo M, Liberini P, Spano P. Dopamine selectively inhibits angiotensin II-induced aldosterone secretion by interacting with D-2 receptors. J Pharmacol Exper Therap. 1988; 246: 1137
   PubMed Web of Science ®Google Scholar
• Carey RM. Acute dopaminergic inhibition of aldosterone secretion is independent of angiotensin II and adrenocorticotropin. J Clin Endocrinol Metab. 1982; 54: 463
   PubMed Web of Science ®Google Scholar
• Malchoff CD, Hughes JM, Sen S, Jackson S, Carey RM. Dopamine inhibits the aldosterone response to upright posture. J Clin Endocrinol Metab. 1986; 63: 197
   PubMed Web of Science ®Google Scholar
• Malchoff CD, Hughes JM, Carey RM. Effect of upright posture on the aldosterone responses to dopamine, metoclopramide, angiotensin II and adrenocorticotropin. J Clin Endocrinol Metab. 1987; 65: 203
   PubMed Web of Science ®Google Scholar
• Coruzzi P, Novarini A, Musiari L, Ravanehi C., Ghielmi S, Rodelle A, et al. The antinatriuretic effect of dopaminergic blockage during volume expansion is independent of circulating atrial natriuretic factor. Clin Science 1989; 77: 479
   PubMed Web of Science ®Google Scholar
• Carey RM, Thorner MO, Ortt EM. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. J Clin Invest. 1980; 66: 10
   PubMed Web of Science ®Google Scholar
• Stern N, Eggena P, Chandler W, Tuck ML. Effects of central and peripheral dopamine antagonism on aldosterone secretion: evidence for adrenal mechanism. Am J Physiol. 1989; 257: E588
   Google Scholar
• Gordon MB, Moore TJ, Dluhy RG, Williams GH. Dopaminergic modulation of aldosterone responsiveness to angiotensin II with changes in sodium intake. J Clin Endocrinol Metab. 1983; 56: 340
   PubMed Web of Science ®Google Scholar
• De Sommers K, Meyer EC, van Wyk M, de Villiers LS. Aldosterone response to metoclopramide is mediated through the autonomic nervous system in man. Eur J Clin Pharmacol. 1988; 33: 609
   PubMed Web of Science ®Google Scholar
• De Sommers K, Meyer EC, van Wyk M. The effect of neostigmine on metoclopramide-induced aldosterone secretion after the administration of muscarinic antagonists in man. Eur J Clin Pharmacol. 1990; 38: 401
   PubMed Web of Science ®Google Scholar
• Stern N, Pullen W, Plasko R, Eggena P, Tuck ML. Evidence for cholinergic modulation of aldosterone secretion in man. J Clin Endocrinol Metab. 1989; 69: 294
   PubMed Web of Science ®Google Scholar
• Cain MD, Walters WAM, Catt KJ. Effects of oral contraceptive therapy on the renin-angiotensin system. J Clin Endocrinol. 1971; 33: 671
   PubMed Web of Science ®Google Scholar
• Nolten WE, Lindheimer MD, Oparil S, Ehrlich EN. Desoxycorticosterone in normal pregnancy. I. Sequential studies of the secretory patterns of desoxycorticosterone, aldosterone and Cortisol. Am J Obstet Gynecol. 1978; 132: 414
   PubMed Web of Science ®Google Scholar
• Jeske W, Soszynski P, Lukaszewicz E, et al. Enhancement of plasma corticotropin-releasing hormone in pregnancy-induced hypertension. Acta Endocrinol (Copenhagen) 1990; 122: 711
   PubMedGoogle Scholar
• Perkins CM, Hancock KW, Cope GF, Lee MR. Urine dopamine in normal and hypertensive pregnancies. Br J Obstet Gynaecol. 1982; 89: 123
   PubMedGoogle Scholar